接受英夫利昔单抗治疗慢性斑块状银屑病的患者出现白癜风。
Vitiligo in a patient receiving infliximab for chronic plaque psoriasis.
机构信息
Department of Dermatology, Shanghai Skin Disease Hospital, Shanghai, China.
出版信息
Dermatol Ther. 2019 May;32(3):e12917. doi: 10.1111/dth.12917. Epub 2019 Apr 29.
PMID:30994249
Abstract
Infliximab is a tumor necrosis factor-alpha (TNF-a) inhibitor widely used in the treatment of moderate to severe chronic plaque psoriasis. Here, we report a case of vitiligo following infliximab administration in a patient with chronic plaque psoriasis. The case serves as a reminder of vitiligo induced by TNF-a-antagonist therapy.
摘要
英夫利昔单抗是一种肿瘤坏死因子-α（TNF-α）抑制剂，广泛用于治疗中重度慢性斑块状银屑病。在此，我们报告了一例慢性斑块状银屑病患者在使用英夫利昔单抗后出现白癜风的病例。该病例提醒我们注意 TNF-α 拮抗剂治疗引起的白癜风。
Zotero 插件